Sarbia M, Gabbert H E
Institut für Pathologie, Heinrich Heine Universität, Düsseldorf, Germany.
Recent Results Cancer Res. 2000;155:15-27. doi: 10.1007/978-3-642-59600-1_2.
In the present study the prognostic impact of new histological and molecular parameters were tested retrospectively in a series of 149 patients with esophageal squamous cell carcinoma (SCC) who underwent potentially curative resection therapy. In addition, the prognostic value of various molecular markers was investigated in a group of 38 patients with locally advanced esophageal SCC treated using combined therapy modalities. In the surgically treated carcinomas, the following morphological parameters proved to be prognostically significant in univariate survival analysis and multivariate survival analysis: pattern of invasion, inflammatory response, and lymph vessel invasion. In contrast, tumor grading according to the criteria of the WHO and tumor cell proliferation did not show significant prognostic impact. Concerning the prognostic influence of molecular parameters, strong expression of the proliferation regulating molecule p21WAF1 and weak expression of the apoptosis regulating molecule Bcl-XL were predictors of poor survival in univariate and multivariate survival analysis. No prognostic impact was shown in relation to the expression of p53 and the apoptosis regulating molecules Bcl-2 and Bax. In the multimodally treated esophageal cancer patients, strong expression of p21WAF1 and accumulation of p53 were predictors of poor survival, whereas expression of Bcl-2, Bax, and Bcl-XL had no prognostic significance. In conclusion, morphological and molecular parameters may provide important prognostic information for esophageal cancer patients.
在本研究中,对149例接受了潜在根治性切除治疗的食管鳞状细胞癌(SCC)患者进行回顾性分析,以检测新的组织学和分子参数的预后影响。此外,在一组采用联合治疗方式治疗的38例局部晚期食管SCC患者中,研究了各种分子标志物的预后价值。在手术治疗的癌症中,以下形态学参数在单因素生存分析和多因素生存分析中被证明具有预后意义:浸润模式、炎症反应和淋巴管浸润。相比之下,根据世界卫生组织标准进行的肿瘤分级和肿瘤细胞增殖并未显示出显著的预后影响。关于分子参数的预后影响,在单因素和多因素生存分析中,增殖调节分子p21WAF1的强表达和凋亡调节分子Bcl-XL的弱表达是生存不良的预测指标。p53以及凋亡调节分子Bcl-2和Bax的表达未显示出预后影响。在接受多模式治疗的食管癌患者中,p21WAF1的强表达和p53的积累是生存不良的预测指标,而Bcl-2、Bax和Bcl-XL的表达没有预后意义。总之,形态学和分子参数可为食管癌患者提供重要的预后信息。